The University of Southampton
University of Southampton Institutional Repository

Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment

Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment
Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment
Objective: To test the hypothesis that: (i) functional microvascular dilator capacity is independently associated with insulin sensitivity and age in individuals with central adiposity at risk of cardiovascular disease (CVD); and (ii) functional microvascular dilator capacity is improved by high dose statin treatment.

Methods: Functional dilator capacity (measured as change in laser Doppler blood flux from baseline during post occlusive reactive hyperemia [peak flux%resting flux; PF%RF] and flowmotion (power spectral density [PSD] analysis)) were assessed in 40 people with central adiposity and one or more other CVD risk factors. Measurements were made at rest and during acute hyperinsulinaemia before and six months after high dose atorvastatin (40 mg daily) or placebo.

Results: Insulin-induced change in PF%RF was independently associated with insulin sensitivity (M/I) (r = 0.46 p = 0.02) and age (r = ?0.46 p = 0.02), which together explained almost half of the variance in PF%RF (adjusted r2 = 0.37, p = 0.008). Whilst atorvastatin decreased LDL cholesterol by 51% (p < 0.001), PF%RF and flowmotion remained unchanged.

Conclusions: Insulin sensitivity and age are independently associated with an insulin-induced change in functional microvascular dilator capacity in individuals with central adiposity at risk of CVD. Dilator capacity is not improved by six months high dose statin treatment
0167-6865
74-84
Clough, Geraldine
9f19639e-a929-4976-ac35-259f9011c494
L'Esperance, Veline
0d44b963-1287-432c-9913-b106064551ce
Turzyniecka, Magdalena Joanna
8368c46e-6803-4750-b56c-518ea1fbf871
Walter, Lara
eaf77899-5915-4f62-9996-bab7676069ae
Chipperfield, Andrew
524269cd-5f30-4356-92d4-891c14c09340
Gamble, John
2e45ff40-aab3-4fca-b553-1f5bcff68ffe
Krentz, A.J.
e2c541b2-1292-4cf1-bc0c-d06f3242156d
Byrne, Christopher D
1370b997-cead-4229-83a7-53301ed2a43c
Clough, Geraldine
9f19639e-a929-4976-ac35-259f9011c494
L'Esperance, Veline
0d44b963-1287-432c-9913-b106064551ce
Turzyniecka, Magdalena Joanna
8368c46e-6803-4750-b56c-518ea1fbf871
Walter, Lara
eaf77899-5915-4f62-9996-bab7676069ae
Chipperfield, Andrew
524269cd-5f30-4356-92d4-891c14c09340
Gamble, John
2e45ff40-aab3-4fca-b553-1f5bcff68ffe
Krentz, A.J.
e2c541b2-1292-4cf1-bc0c-d06f3242156d
Byrne, Christopher D
1370b997-cead-4229-83a7-53301ed2a43c

Clough, Geraldine, L'Esperance, Veline, Turzyniecka, Magdalena Joanna, Walter, Lara, Chipperfield, Andrew, Gamble, John, Krentz, A.J. and Byrne, Christopher D (2010) Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment. International Journal of Microcirculation, 18 (1), 74-84. (doi:10.1111/j.1549-8719.2010.00070.x). (PMID:21166928)

Record type: Article

Abstract

Objective: To test the hypothesis that: (i) functional microvascular dilator capacity is independently associated with insulin sensitivity and age in individuals with central adiposity at risk of cardiovascular disease (CVD); and (ii) functional microvascular dilator capacity is improved by high dose statin treatment.

Methods: Functional dilator capacity (measured as change in laser Doppler blood flux from baseline during post occlusive reactive hyperemia [peak flux%resting flux; PF%RF] and flowmotion (power spectral density [PSD] analysis)) were assessed in 40 people with central adiposity and one or more other CVD risk factors. Measurements were made at rest and during acute hyperinsulinaemia before and six months after high dose atorvastatin (40 mg daily) or placebo.

Results: Insulin-induced change in PF%RF was independently associated with insulin sensitivity (M/I) (r = 0.46 p = 0.02) and age (r = ?0.46 p = 0.02), which together explained almost half of the variance in PF%RF (adjusted r2 = 0.37, p = 0.008). Whilst atorvastatin decreased LDL cholesterol by 51% (p < 0.001), PF%RF and flowmotion remained unchanged.

Conclusions: Insulin sensitivity and age are independently associated with an insulin-induced change in functional microvascular dilator capacity in individuals with central adiposity at risk of CVD. Dilator capacity is not improved by six months high dose statin treatment

This record has no associated files available for download.

More information

Accepted/In Press date: 3 November 2010
e-pub ahead of print date: 10 November 2010
Published date: 23 December 2010
Additional Information: © 2010 John Wiley & Sons Ltd

Identifiers

Local EPrints ID: 181121
URI: http://eprints.soton.ac.uk/id/eprint/181121
ISSN: 0167-6865
PURE UUID: cd375ed0-5527-4507-bd4a-f5a25ce31e84
ORCID for Geraldine Clough: ORCID iD orcid.org/0000-0002-6226-8964
ORCID for Andrew Chipperfield: ORCID iD orcid.org/0000-0002-3026-9890
ORCID for Christopher D Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 15 Apr 2011 10:42
Last modified: 15 Mar 2024 03:15

Export record

Altmetrics

Contributors

Author: Veline L'Esperance
Author: Magdalena Joanna Turzyniecka
Author: Lara Walter
Author: John Gamble
Author: A.J. Krentz

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×